Secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves overall survival in ...
In over 400 women at first epithelial ovarian cancer recurrence, those who received HIPEC had a median OS of 54.3 months compared with 45.8 months for those who did not (HR 0.73, 95% CI 0.56-0.96, P=0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback